How New Muscle Cell Technology Is Making Cultivated Meat Affordable

A new EU-backed project claims it's cracked part of that code, and the implications go beyond the petri dish.

What PROFUSE Actually Built

The EU-funded PROFUSE project, coordinated by a company called ProFuse, zeroed in on the one tissue that matters most: muscle. Steak is muscle. Chicken breast is muscle. If you can't grow mature muscle fibres efficiently, you're just making expensive protein mush.

Their answer is a growth supplement called PROFUSE-S1, designed to push young muscle cells — myoblasts, specifically — into fully mature fibres faster and more efficiently. Why myoblasts and not fibroblasts or embryonic stem cells? Because myoblasts actually become the kind of tissue that gives meat its texture, structure, and protein punch. The team also developed a second-generation version, PROFUSE-S2, tested in 3D systems that mimic real factory production rather than flat lab dishes.

On top of that, they delivered a non-GMO bovine cell line purpose-built for cultivated meat production. No genetic modification, no regulatory headaches — just a reliable, scalable source of beef muscle cells that producers can actually work with.

The Cost Problem — And a Real-World Fix

Here's where it gets practical. PROFUSE didn't just tinker in isolation. They partnered with cultivated meat companies, including SuperMeat, to test both the supplement and the cell line in actual production environments. The results: reduced production costs per kilogram, faster cell maturation into functional muscle tissue, and significantly increased overall muscle yield. That's not a press-release promise — it's a process improvement with measurable output.

The project coordinator, Guy Nevo Michrowski, framed the core challenge bluntly: cultivated meat needs cost parity with farm-grown meat, industrial-scale production, and quality that doesn't taste like a compromise. PROFUSE addresses the first two directly by making the growth phase shorter and more productive.

Meanwhile, infrastructure gaps are being tackled elsewhere too. Tufts University recently launched an Innovation Hub for Food and Materials in Massachusetts, offering shared cell culture, bioprocessing, and scale-up facilities to startups and researchers who lack their own labs. David Kaplan, a professor of engineering at Tufts, pointed out that the recurring barrier for both academia and industry is access to the right infrastructure at the right stage. The hub connects directly with Tufts' Center for Cellular Agriculture, which researches cultivated meat and alternative proteins — and earlier this year, Tufts partnered with the Good Food Institute to preserve cultivated meat cell lines for open industry use.

These aren't isolated moves. Across Southeast Asia, similar collaborative science models are transforming regional food systems through sustainable innovation and shared research — the same principle, different geography.

Bottom Line: What This Means for You

If you follow the cultivated meat space — whether as a curious eater, an investor, or someone tracking protein alternatives for dietary reasons — here's what to take away:

• Non-GMO muscle cell lines are now on the table. That matters for regulatory approval in markets where GMO labels kill consumer trust.
• Growth supplements that accelerate maturation directly cut cost per kilogram. The gap between lab-grown and farm-grown meat is narrowing, not in theory but in tested production runs.
• Shared infrastructure is becoming a real thing. From EU-funded projects to university hubs, the "you need a billion-dollar lab" excuse is fading for smaller players.
• Texture is the new frontier. Anyone can grow cells. Growing muscle fibres that actually chew like meat? That's the PROFUSE bet — and early results suggest it's paying off.

Don't expect cultivated steak at your grocery store next month. But the enabling technologies are maturing faster than the cells themselves, and that's the signal worth watching.